Jpmorgan Chase & CO Genmab A/S Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Genmab A/S stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,943 shares of GMAB stock, worth $282,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,943
Previous 27,510 52.95%
Holding current value
$282,157
Previous $691,000 54.41%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
SELL
$23.84 - $28.48 $347,277 - $414,868
-14,567 Reduced 52.95%
12,943 $315,000
Q3 2024

Nov 08, 2024
SELL
$23.84 - $28.48 $347,277 - $414,868
-14,567 Reduced 52.95%
12,943 $315,000
Q2 2024

Dec 26, 2024
BUY
$25.13 - $30.27 $366,068 - $440,943
14,567 Added 112.55%
27,510 $691,000
Q2 2024

Aug 12, 2024
SELL
$25.13 - $30.27 $109,918 - $132,400
-4,374 Reduced 13.72%
27,510 $691,000
Q1 2024

Dec 26, 2024
BUY
$26.43 - $32.77 $500,610 - $620,696
18,941 Added 146.34%
31,884 $953,000
Q1 2024

May 10, 2024
SELL
$26.43 - $32.77 $2.75 Million - $3.41 Million
-104,019 Reduced 76.54%
31,884 $953,000
Q4 2023

Dec 26, 2024
BUY
$27.94 - $35.44 $3.44 Million - $4.36 Million
122,960 Added 950.01%
135,903 $4.33 Million
Q4 2023

Feb 12, 2024
SELL
$27.94 - $35.44 $1.12 Million - $1.42 Million
-40,091 Reduced 22.78%
135,903 $4.33 Million
Q3 2023

Nov 14, 2023
BUY
$35.27 - $42.24 $1.85 Million - $2.22 Million
52,528 Added 42.54%
175,994 $6.21 Million
Q2 2023

Aug 11, 2023
SELL
$37.4 - $42.94 $1.62 Million - $1.86 Million
-43,281 Reduced 25.96%
123,466 $4.69 Million
Q1 2023

May 11, 2023
SELL
$34.88 - $43.22 $1.14 Million - $1.41 Million
-32,546 Reduced 16.33%
166,747 $6.3 Million
Q4 2022

Feb 13, 2023
BUY
$33.8 - $47.06 $660,722 - $919,928
19,548 Added 10.88%
199,293 $8.45 Million
Q3 2022

Nov 14, 2022
BUY
$31.52 - $373.61 $200,372 - $2.38 Million
6,357 Added 3.67%
179,745 $5.78 Million
Q2 2022

Aug 11, 2022
BUY
$26.83 - $38.57 $1.03 Million - $1.48 Million
38,272 Added 28.33%
173,388 $5.63 Million
Q1 2022

May 11, 2022
BUY
$30.95 - $39.68 $1.25 Million - $1.6 Million
40,444 Added 42.72%
135,116 $4.89 Million
Q4 2021

Feb 10, 2022
SELL
$35.87 - $47.12 $839,465 - $1.1 Million
-23,403 Reduced 19.82%
94,672 $3.74 Million
Q3 2021

Nov 12, 2021
BUY
$41.55 - $48.72 $4.91 Million - $5.75 Million
118,075 New
118,075 $5.16 Million

Others Institutions Holding GMAB

# of Institutions
237
Shares Held
52.5M
Call Options Held
10.2K
Put Options Held
25.5K
View Full List

About GENMAB A/S

GMAB Quotes by TradingView
  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $14.4B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email